Significantly increased threshold dose after long-term peanut epicutaneous immunotherapy and daily oral peanut intake
Ann Allergy Asthma Immunol
.
2020 Apr;124(4):403-405.e1.
doi: 10.1016/j.anai.2020.01.021.
Epub 2020 Feb 20.
Authors
Whitney Reid Fink
1
,
Peter Capucilli
2
,
Megan O Lewis
2
,
Courtney B Rooney
2
,
Terri F Brown-Whitehorn
2
Affiliations
1
Children's Hospital of Philadelphia, Pennsylvania. Electronic address: Finkw@email.chop.edu.
2
Children's Hospital of Philadelphia, Pennsylvania.
PMID:
32006703
DOI:
10.1016/j.anai.2020.01.021
No abstract available
Publication types
Case Reports
Letter
Research Support, Non-U.S. Gov't
MeSH terms
Adolescent
Desensitization, Immunologic / methods*
Humans
Male
Peanut Hypersensitivity / prevention & control*